Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
943648522 | 9436485 | 22 | F | 20130715 | 20160711 | 20130802 | 20160720 | EXP | CA-ROCHE-1255439 | ROCHE | 64.44 | YR | M | Y | 0.00000 | 20160720 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
943648522 | 9436485 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | 150 | MG | |||||||
943648522 | 9436485 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 9 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 10 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 11 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 12 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 13 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 14 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E,S0001E,S0066B | 103976 | |||||||||
943648522 | 9436485 | 15 | SS | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
943648522 | 9436485 | 1 | Asthma |
943648522 | 9436485 | 15 | Cough |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
943648522 | 9436485 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
943648522 | 9436485 | Asthma | |
943648522 | 9436485 | Blood pressure systolic increased | |
943648522 | 9436485 | Body temperature decreased | |
943648522 | 9436485 | Hypoventilation | |
943648522 | 9436485 | Infection | |
943648522 | 9436485 | Lower respiratory tract infection | |
943648522 | 9436485 | Nasopharyngitis | |
943648522 | 9436485 | Paranasal sinus hypersecretion | |
943648522 | 9436485 | Polyp | |
943648522 | 9436485 | Respiratory tract infection fungal | |
943648522 | 9436485 | Sinusitis | |
943648522 | 9436485 | Type 2 diabetes mellitus | |
943648522 | 9436485 | Upper respiratory tract infection | |
943648522 | 9436485 | Vitamin B12 decreased | |
943648522 | 9436485 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
943648522 | 9436485 | 1 | 20130527 | 0 | ||
943648522 | 9436485 | 2 | 20131105 | 0 | ||
943648522 | 9436485 | 3 | 20131203 | 0 | ||
943648522 | 9436485 | 4 | 20140128 | 0 | ||
943648522 | 9436485 | 5 | 20140818 | 0 | ||
943648522 | 9436485 | 6 | 20150105 | 0 | ||
943648522 | 9436485 | 7 | 20150202 | 0 | ||
943648522 | 9436485 | 8 | 20150629 | 0 | ||
943648522 | 9436485 | 9 | 20150921 | 0 | ||
943648522 | 9436485 | 10 | 20160111 | 0 | ||
943648522 | 9436485 | 11 | 20160418 | 0 | ||
943648522 | 9436485 | 12 | 20160518 | 0 | ||
943648522 | 9436485 | 13 | 20160613 | 0 | ||
943648522 | 9436485 | 14 | 20160711 | 0 | ||
943648522 | 9436485 | 15 | 20150824 | 0 |